Cargando…
The pharmacologic basis of high dose chemotherapy with haematopoietic stem cell support for solid tumours
The theoretical basis of high dose chemotherapy with haematopoietic stem cell support (HDT) for solid tumours is the presumption of a linear, steep dose-response relationship for chemotherapy conditioning agents. We review preclinical pharmacologic studies evaluating steep dose-response relationship...
Autores principales: | Porrata, L F, Adjei, A A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364096/ https://www.ncbi.nlm.nih.gov/pubmed/11506483 http://dx.doi.org/10.1054/bjoc.2001.1970 |
Ejemplares similares
-
Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
por: Leung, W, et al.
Publicado: (2007) -
The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis
por: Main, Caroline, et al.
Publicado: (2015) -
Pharmacological Basis of Cancer Chemotherapy
por: Fox, B. W., et al.
Publicado: (1976) -
Clostridium difficile Infection in Solid Organ and Haematopoietic Stem Cell Transplant Recipients
por: Ilett, Emma Elizabeth, et al.
Publicado: (2017) -
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
por: Snowden, John A., et al.
Publicado: (2022)